There is evidence that loss of MTAP results in an inhibition of STAT signalling pathways regulated by interferon, so it is of interest that response of melanoma patients to interferon used as an adjuvant therapy for this cancer has been reported to be related to MTAP status (Wild et al.,2007). This evidence concerns the gene MTAP and cancer.